compound introduction
GSK-2793660 is an orally active and irreversible inhibitor of Cathepsin C ( CTSC ). GSK-2793660 can be used for the research of bronchiectasis. Appearance:Solid IC50& Target:Cathepsin C (CTSC) In Vivo:GSK-2793660 is a cathepsin C (also known as dipeptidyl peptidase I enzyme) inhibitor for the reaearch of cystic fibrosis, non-cystic fibrosis bronchiectasis, anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis and bronchiectasis. MC Biological Activity:GSK-2793660 is an orally active and irreversible inhibitor of Cathepsin C ( CTSC ). GSK-2793660 can be used for the research of bronchiectasis .
